LOW-GRADE SEROUS OVARIAN CANCER IS

Serious

Low-Grade Serous Ovarian Cancer (LGSOC) Resources

New treatments are being studied in clinical trials right now.

This is where you’ll find the latest information about clinical trials, articles about treatment, and news about all things related to low-grade serous ovarian cancer (also known as LGSOC).

Bookmark this page and come back often so you don’t miss out on new developments in the treatment of LGSOC.

New treatments are being studied in clinical trials right now.

This is where you’ll find the latest information about clinical trials, articles about treatment, and news about all things related to low-grade serous ovarian cancer (also known as LGSOC).

Bookmark this page and come back often so you don’t miss out on new developments in the treatment of LGSOC.

Clinical trial finder

Stay up to date on clinical trials for LGSOC through these websites:

NIH U.S. National Library of Medicine ClinicalTrials.gov
Cure Ovarian Cancer logo

Search for “low grade” when using the OCRA (Ovarian Cancer Research Alliance) clinical trial finder.

Ovarian Cancer Research Alliance logo

Clinical trial finder

Stay up to date on clinical trials for LGSOC through these websites:

NIH U.S. National Library of Medicine ClinicalTrials.gov
Cure Ovarian Cancer logo

Search for “low grade” when using the OCRA (Ovarian Cancer Research Alliance) clinical trial finder.

Ovarian Cancer Research Alliance logo

LGSOC Patient Impact Survey Results

We are pleased to present the results from the LGSOC Patient Impact Survey, a first-of-its-kind, multi-national survey among women diagnosed with low-grade serous ovarian cancer (LGSOC). View survey details, including methodology, audience demographics, survey data and more.

LGSOC Glossary

Navigating medical terms can be challenging. Use this glossary of commonly used words and phrases associated with LGSOC to help you feel more prepared when talking to your care team.

Patient Webinar: Let’s Talk About Clinical Trials

Hear from leading gynecologic oncologist, Dr. Jubilee Brown, on recent progress in research evaluating treatments for LGSOC.  Dr. Brown also discusses the importance of clinical trials and resources for finding them.

Talk to your doctor about LGSOC